The Korea Food and Drug Administration announced that a total of 3,111 drugs will be re-evaluated this year under the provisions of the Korea Pharmaceutical Affairs Laws.
Of the 3,111 items, the number of re-assessment for bioequivalence testing is 886 but the KFDA did not received related bioequivalence data on 105 items.
A KFDA official said that the deadline for submission of bioequiva...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.